Well enzyme replacement biologic drugs didn't fit with simple ADHD drugs either. Interesting to me the planned IPO price was $18.00 and they were taken out at the equivalent of $18.60. Great story though coming out of bankruptcy, major debacle to a success story. This is the former Organogenesis.